Handok to expand Amaryl M production capacity

Handok Pharmaceutical said recently that it has invested 20 billion won on remodeling a plant in Eumsung of North Chungcheng Province to expand its output capacity of Amaryl M, generic version of Amaryl and and the leading oral antidiabetic.

The plant, which was designed under advanced GEP (Good Engineering Practice), will have an annual production capacity of 1.6 billion tablets, with an ul...